Temat: "screening" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Zebrafish-Based Screening Models for the Identification of Anti-Metastatic Drugs.
Autorzy :: Nakayama J; Shonai Regional Industry Promotion Center, Tsuruoka, Yamagata, 997-0052, Japan.; Tsuruoka Metabolomics Laboratory, National Cancer Center, Mizukami 246-2, Kakuganji, Tsuruoka, Yamagata 975-0052, Japan.
Makinoshima H; Tsuruoka Metabolomics Laboratory, National Cancer Center, Mizukami 246-2, Kakuganji, Tsuruoka, Yamagata 975-0052, Japan.; Division of Translational Research, Exploratory Oncology Research, and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba 277-8577, Japan.; Pokaż więcej
Źródło :: Molecules (Basel, Switzerland) [Molecules] 2020 May 21; Vol. 25 (10). Date of Electronic Publication: 2020 May 21.
Typ publikacji :: Journal Article; Review
MeSH Terms :: High-Throughput Screening Assays*
Antineoplastic Agents/*pharmacology
Neoplasm Metastasis/*drug therapy
Neovascularization, Pathologic/*drug therapy
Animals ; Antineoplastic Agents/chemistry ; Cell Line, Tumor ; Cell Movement/drug effects ; Disease Models, Animal ; Drug Screening Assays, Antitumor/methods ; Humans ; Neoplasm Invasiveness/genetics ; Neoplasm Invasiveness/pathology ; Neoplasm Metastasis/pathology ; Neovascularization, Pathologic/pathology ; Tumor Microenvironment/drug effects ; Zebrafish
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 2 2.

Tytuł :: Random vs Targeted Urine Drug Testing Among Patients Undergoing Long-term Opioid Treatment for Cancer Pain.
Autorzy :: Arthur J; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Lu Z; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Nguyen K; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Hui D; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Prado B; Department of Oncology and Hematology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Edwards T; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.
Bruera E; Department of Palliative, Rehabilitation and Integrative Medicine, The University of Texas MD Anderson Cancer Center, Houston.; Pokaż więcej
Źródło :: JAMA oncology [JAMA Oncol] 2020 Apr 01; Vol. 6 (4), pp. 580-581.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Screening Assays, Antitumor*
Analgesics, Opioid/*urine
Cancer Pain/*drug therapy
Neoplasms/*urine
Cancer Pain/pathology ; Cancer Pain/urine ; Chronic Pain/drug therapy ; Chronic Pain/urine ; Female ; Humans ; Male ; Mass Screening ; Middle Aged ; Neoplasms/complications ; Neoplasms/drug therapy ; Pain Management/methods
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 3 3.

Tytuł :: Antigenicity, stability, and reproducibility of Zika reporter virus particles for long-term applications.
Autorzy :: Whitbeck JC; Integral Molecular, Inc., Philadelphia, PA, United States of America.
Thomas A; Integral Molecular, Inc., Philadelphia, PA, United States of America.
Kadash-Edmondson K; Integral Molecular, Inc., Philadelphia, PA, United States of America.
Grinyo-Escuer A; Integral Molecular, Inc., Philadelphia, PA, United States of America.
Stafford LJ; Integral Molecular, Inc., Philadelphia, PA, United States of America.
Cheng C; Vitalant Research Institute, San Francisco, CA, United States of America.
Liao GC; Integrated Biotherapeutics, 4 Research Court, Rockville, MD, United States of America.
Holtsberg FW; Integrated Biotherapeutics, 4 Research Court, Rockville, MD, United States of America.
Aman MJ; Integrated Biotherapeutics, 4 Research Court, Rockville, MD, United States of America.
Simmons G; Vitalant Research Institute, San Francisco, CA, United States of America.
Davidson E; Integral Molecular, Inc., Philadelphia, PA, United States of America.
Doranz BJ; Integral Molecular, Inc., Philadelphia, PA, United States of America.; Pokaż więcej
Źródło :: PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2020 Nov 18; Vol. 14 (11), pp. e0008730. Date of Electronic Publication: 2020 Nov 18 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Validation Study
MeSH Terms :: Antibodies, Neutralizing/*blood
Antibodies, Viral/*blood
High-Throughput Screening Assays/*methods
Neutralization Tests/*methods
Zika Virus/*immunology
Zika Virus Infection/*diagnosis
Animals ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; Antibodies, Viral/immunology ; Cell Line ; Chlorocebus aethiops ; Cricetinae ; Genes, Reporter/genetics ; HEK293 Cells ; Humans ; Mass Screening/methods ; Vero Cells ; Viral Vaccines/immunology ; Zika Virus/genetics ; Zika Virus Infection/prevention & control
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 4 4.

Tytuł :: Experience with Parent Follow-Up for Communication Outcomes after Newborn Screening Identifies Carrier Status.
Autorzy :: Farrell MH; Mayo Clinic Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN; Center for Patient Care and Reactions Research, Medical College of Wisconsin, Milwaukee, WI. Electronic address: .
La Pean Kirschner A; Center for Patient Care and Reactions Research, Medical College of Wisconsin, Milwaukee, WI.
Tluczek A; University of Wisconsin-Madison School of Nursing, Madison, WI.
Farrell PM; Departments of Pediatrics and Population Health Sciences, University of Wisconsin School of Medicine and Public Health, Madison, WI.; Pokaż więcej
Źródło :: The Journal of pediatrics [J Pediatr] 2020 Sep; Vol. 224, pp. 37-43.e2. Date of Electronic Publication: 2020 May 06.
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :: Health Knowledge, Attitudes, Practice*
Anemia, Sickle Cell/*genetics
Carrier State/*psychology
Cystic Fibrosis/*genetics
Genetic Carrier Screening/*standards
Parents/*psychology
Anxiety/diagnosis ; Carrier State/diagnosis ; Cohort Studies ; Female ; Genetic Carrier Screening/ethics ; Humans ; Infant ; Infant, Newborn ; Informed Consent ; Male ; Neonatal Screening ; Patient Satisfaction ; Physician-Patient Relations ; Qualitative Research ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Newborn screening for CF in France: An exemplary national experience.
Autorzy :: Audrézet MP; CHU Brest, Inserm, UMR 1078, F-29200, Brest, France. Electronic address: .
Munck A; Société Française de Dépistage Néonatal, France; CRCM Hopital Necker Enfants Malades, Paris.; Pokaż więcej
Źródło :: Archives de pediatrie : organe officiel de la Societe francaise de pediatrie [Arch Pediatr] 2020 Feb; Vol. 27 Suppl 1, pp. eS35-eS40.
Typ publikacji :: Journal Article
MeSH Terms :: Neonatal Screening*
Cystic Fibrosis/*diagnosis
Algorithms ; Biomarkers/metabolism ; Cystic Fibrosis/genetics ; Cystic Fibrosis Transmembrane Conductance Regulator/genetics ; France ; Genetic Carrier Screening ; Genetic Counseling ; Genetic Testing ; Health Policy ; Humans ; Infant, Newborn ; Mutation ; Pancreatitis-Associated Proteins/metabolism ; Sweat/chemistry
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: Universal Electrocardiographic Screening for Long QT Syndrome in Hospitalized Neonates.
Autorzy :: Kaemingk BD; Division of Neonatal Medicine, Mayo Clinic, Rochester, Minnesota.
Ulrich TJ; Division of Neonatal-Perinatal Medicine, St. Luke's Health System, Boise, Idaho.
Li M; Department of Information Technology, Multidisciplinary Epidemiology and Translational Research in Intensive Care, Mayo Clinic, Rochester, Minnesota.
Carey WA; Division of Neonatal Medicine, Mayo Clinic, Rochester, Minnesota.
Ellsworth MA; Division of Neonatology, Banner - University Medical Center Phoenix, Phoenix, Arizona.; Division of Neonatology, Cardon Children's Medical Center, Banner Health, Mesa, Arizona.; Pokaż więcej
Źródło :: American journal of perinatology [Am J Perinatol] 2020 Feb; Vol. 37 (3), pp. 322-325. Date of Electronic Publication: 2019 Feb 04.
Typ publikacji :: Journal Article
MeSH Terms :: Electrocardiography*
Neonatal Screening*
Infant, Premature, Diseases/*diagnosis
Long QT Syndrome/*diagnosis
Cohort Studies ; Female ; Gestational Age ; Humans ; Infant, Newborn ; Infant, Premature ; Intensive Care Units, Neonatal ; Male ; Mass Screening ; Predictive Value of Tests
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement.
Autorzy :: Xie B; Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China; Department of Medical Biochemistry and Microbiology, University of Uppsala, Uppsala, Sweden.
He X; Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Guo G; Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang, China.
Zhang X; Department of Neuroscience, University of Uppsala, Uppsala, Sweden.
Li J; Department of Medical Biochemistry and Microbiology, University of Uppsala, Uppsala, Sweden.
Liu J; School of Clinical Medicine, Dali University, Yunnan, China. Electronic address: .
Lin Y; Department of Oncology-Pathology, Karolinska Institute, Stockholm, Sweden. Electronic address: .; Pokaż więcej
Źródło :: Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2020 Jan 01; Vol. 521 (1), pp. 232-237. Date of Electronic Publication: 2019 Oct 22.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: High-Throughput Screening Assays*
Antineoplastic Agents/*pharmacology
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Mitoxantrone/*pharmacology
Small Molecule Libraries/*pharmacology
Carcinoma, Hepatocellular/pathology ; Cell Death/drug effects ; Cell Proliferation/drug effects ; Dose-Response Relationship, Drug ; Drug Screening Assays, Antitumor ; Hep G2 Cells ; Humans ; Liver Neoplasms/pathology ; Tumor Cells, Cultured
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: A fluorescence-based high throughput-screening assay for the SARS-CoV RNA synthesis complex.
Autorzy :: Eydoux C; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Antiviral Drug Design Platform Marseille, France.
Fattorini V; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France.
Shannon A; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France.
Le TT; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France.
Didier B; Université de Strasbourg, CNRS UMR7200, Laboratoire d'Excellence Medalis, Faculté de Pharmacie, 74 route du Rhin, 67401, Illkirch, France.
Canard B; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France. Electronic address: .
Guillemot JC; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France; Aix-Marseille Univ, CNRS, AFMB UMR 7257, Antiviral Drug Design Platform Marseille, France. Electronic address: .; Pokaż więcej
Źródło :: Journal of virological methods [J Virol Methods] 2021 Feb; Vol. 288, pp. 114013. Date of Electronic Publication: 2020 Nov 06.
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Fluorescent Dyes*
High-Throughput Screening Assays*/methods
High-Throughput Screening Assays*/standards
RNA, Viral*
RNA-Dependent RNA Polymerase/*metabolism
SARS Virus/*genetics
Severe Acute Respiratory Syndrome/*diagnosis
Severe Acute Respiratory Syndrome/*genetics
Antiviral Agents/pharmacology ; Dose-Response Relationship, Drug ; Drug Evaluation, Preclinical ; Enzyme Activation ; Humans ; Inhibitory Concentration 50 ; RNA, Messenger/genetics ; Templates, Genetic
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Increasing hepatitis virus screening uptake at worksites in Japan using nudge theory and full subsidies.
Autorzy :: Fukuyoshi J; Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Shinanomachi, Tokyo, 160-8582, Japan.
Korenaga M; Hepatitis Information Center, The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Chiba, 272-8516, Japan. .
Yoshii Y; Department of Social and Preventive Epidemiology, School of Public Health, Graduate School of Medicine, Tokyo University, Hongo, Tokyo, 113-0033, Japan.
Hong L; Department of Policy Management, Keio University, Fujisawa, Kanagawa, 252-0882, Japan.
Kashihara S; Cancerscan, Co., Ltd., Shinagawa, Tokyo, 141-0031, Japan.
Sigel B; School of International Health, Graduate School of Medicine, Tokyo University, Hongo, Tokyo, 113-0033, Japan.
Takebayashi T; Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Shinanomachi, Tokyo, 160-8582, Japan.; Pokaż więcej
Źródło :: Environmental health and preventive medicine [Environ Health Prev Med] 2021 Feb 01; Vol. 26 (1), pp. 18. Date of Electronic Publication: 2021 Feb 01.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Cost-Benefit Analysis*
Workplace*
Hepatitis Viruses/*isolation & purification
Mass Screening/*instrumentation
Adult ; Aged ; Aged, 80 and over ; Female ; Humans ; Japan ; Male ; Mass Screening/economics ; Middle Aged
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: --A high-throughput screen identifies inhibitors of the interaction between the oncogenic transcription factor ERG and the cofactor EWS.
Autorzy :: Nicholas TR; Department of Biology, Indiana University, Bloomington, Indiana, United States of America.
Meng J; Chemical Genomics Core Facility, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
Greulich BM; Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana, United States of America.
Morris TS; Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana, United States of America.
Hollenhorst PC; Medical Sciences, Indiana University School of Medicine, Bloomington, Indiana, United States of America.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Sep 11; Vol. 15 (9), pp. e0238999. Date of Electronic Publication: 2020 Sep 11 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :: High-Throughput Screening Assays/*methods
Prostatic Neoplasms/*drug therapy
Prostatic Neoplasms/*metabolism
RNA-Binding Protein EWS/*antagonists & inhibitors
Cell Line, Tumor ; Drug Screening Assays, Antitumor/methods ; Feasibility Studies ; Humans ; Male ; Prostatic Neoplasms/genetics ; Protein Interaction Domains and Motifs/drug effects ; RNA-Binding Protein EWS/genetics ; RNA-Binding Protein EWS/metabolism ; Recombinant Proteins/drug effects ; Recombinant Proteins/genetics ; Recombinant Proteins/metabolism ; Small Molecule Libraries ; Transcriptional Regulator ERG/antagonists & inhibitors ; Transcriptional Regulator ERG/genetics ; Transcriptional Regulator ERG/metabolism
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 11 11.

Tytuł :: Membrane dynamics simulation and virtual screening reveals potential dual natural inhibitors of endothelin receptors for targeting glaucomatous condition.
Autorzy :: Nagarajan H; Centre for Bioinformatics, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision Research Foundation, Sankara Nethralaya, Chennai 600 006, Tamil Nadu, India.
Vetrivel U; Centre for Bioinformatics, Kamalnayan Bajaj Institute for Research in Vision and Ophthalmology, Vision Research Foundation, Sankara Nethralaya, Chennai 600 006, Tamil Nadu, India; National Institute of Traditional Medicine, Indian Council of Medical Research, Department of Health Research (Govt. of India), Belagavi 590010, India. Electronic address: .; Pokaż więcej
Źródło :: Life sciences [Life Sci] 2021 Mar 15; Vol. 269, pp. 119082. Date of Electronic Publication: 2021 Jan 19.
Typ publikacji :: Journal Article
MeSH Terms :: High-Throughput Screening Assays*
Molecular Docking Simulation*
Endothelin Receptor Antagonists/*chemistry
Endothelin Receptor Antagonists/*pharmacology
Glaucoma/*drug therapy
Receptor, Endothelin A/*chemistry
Receptor, Endothelin B/*chemistry
Amino Acid Sequence ; Glaucoma/metabolism ; Humans ; Protein Conformation ; Retinal Ganglion Cells/drug effects ; Sequence Homology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 12 12.

Tytuł :: A systematic review of technological approaches for autism spectrum disorder assessment in children: Implications for the COVID-19 pandemic.
Autorzy :: Dahiya AV; Virginia Polytechnic Institute and State University, Department of Psychology, 109 Williams Hall, Blacksburg, VA, 24060, United States; Virginia Tech Autism Clinic & Center for Autism Research, 3110 Prices Fork Road, Blacksburg, VA, 24060, United States. Electronic address: .
DeLucia E; Virginia Polytechnic Institute and State University, Department of Psychology, 109 Williams Hall, Blacksburg, VA, 24060, United States; Virginia Tech Autism Clinic & Center for Autism Research, 3110 Prices Fork Road, Blacksburg, VA, 24060, United States.
McDonnell CG; Virginia Polytechnic Institute and State University, Department of Psychology, 109 Williams Hall, Blacksburg, VA, 24060, United States; Virginia Tech Autism Clinic & Center for Autism Research, 3110 Prices Fork Road, Blacksburg, VA, 24060, United States.
Scarpa A; Virginia Polytechnic Institute and State University, Department of Psychology, 109 Williams Hall, Blacksburg, VA, 24060, United States; Virginia Tech Autism Clinic & Center for Autism Research, 3110 Prices Fork Road, Blacksburg, VA, 24060, United States.; Pokaż więcej
Źródło :: Research in developmental disabilities [Res Dev Disabil] 2021 Feb; Vol. 109, pp. 103852. Date of Electronic Publication: 2021 Jan 08.
Typ publikacji :: Journal Article; Systematic Review
MeSH Terms :: COVID-19*/epidemiology
COVID-19*/prevention & control
Mass Screening*/methods
Mass Screening*/trends
Autism Spectrum Disorder/*diagnosis
Communicable Disease Control/*methods
Telemedicine/*methods
Child ; Humans ; Inventions
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 13 13.

Tytuł :: Bowel cancer screening in older patients: is it time to reconsider?
Autorzy :: Frommer DJ; University of New South Wales, Sydney, NSW.; University of Sydney, Sydney, NSW.; Pokaż więcej
Źródło :: The Medical journal of Australia [Med J Aust] 2021 Feb; Vol. 214 (3), pp. 143-143.e1. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :: Letter
MeSH Terms :: Colorectal Neoplasms/*diagnosis
Mass Screening/*statistics & numerical data
Age Factors ; Aged ; Australia ; Female ; Humans ; Male ; Mass Screening/trends ; Middle Aged
: Opinia redakcyjna

Szczegóły

Skocz do pozycji: 14 14.

Tytuł :: Community-based intervention for cervical cancer screening uptake in a semi-urban area of Pokhara Metropolitan, Nepal (COBIN-C): study protocol for a cluster-randomized controlled trial.
Autorzy :: Shrestha AD; Center for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark. .; COBIN, Nepal Development Society, Bharatpur, Nepal. .
Neupane D; COBIN, Nepal Development Society, Bharatpur, Nepal.; Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ghimire S; Nepal Cancer Care Foundation, Lalitpur, Nepal.
Campbell C; Usher Institute, University of Edinburgh, Edinburgh, EH8 9AG, UK.
Kallestrup P; Center for Global Health, Department of Public Health, Aarhus University, Aarhus, Denmark.; Pokaż więcej
Źródło :: Trials [Trials] 2021 Jan 26; Vol. 22 (1), pp. 94. Date of Electronic Publication: 2021 Jan 26.
Typ publikacji :: Clinical Trial Protocol; Journal Article
MeSH Terms :: Early Detection of Cancer/*statistics & numerical data
Health Education/*organization & administration
Mass Screening/*organization & administration
Patient Acceptance of Health Care/*statistics & numerical data
Uterine Cervical Neoplasms/*diagnosis
Adult ; Community Health Workers/organization & administration ; Community Participation ; Female ; Health Plan Implementation ; Humans ; Mass Screening/statistics & numerical data ; Middle Aged ; Nepal ; Program Evaluation ; Randomized Controlled Trials as Topic ; Treatment Outcome ; Urban Population ; Volunteers
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
Autorzy :: Kalsi JK; Department of Women's Cancer, Institute for Women's Health, University College London, London, WC1E 6AU, UK.
Ryan A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Gentry-Maharaj A; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Margolin-Crump D; Department of Women's Cancer, Institute for Women's Health, University College London, London, WC1E 6AU, UK.
Singh N; Department of Cellular Pathology, Barts Health NHS Trust, London, E1 2ES, UK.
Burnell M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Benjamin E; HCA International, Pathology Laboratories, London, WC1E 6JA, UK.
Apostolidou S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Habib M; Department of Women's Cancer, Institute for Women's Health, University College London, London, WC1E 6AU, UK.; Imperial Clinical Trials Unit, Imperial College London, London, W12 7RH, UK.
Massingham S; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Karpinskyj C; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Woolas R; Department of Gynaecological Oncology, Queen Alexandra Hospital, Portsmouth, PO6 3LY, UK.
Widschwendter M; Department of Women's Cancer, Institute for Women's Health, University College London, London, WC1E 6AU, UK.
Fallowfield L; Sussex Health Outcomes Research and Education in Cancer (SHORE-C), Brighton and Sussex Medical School, University of Sussex, Brighton, BN1 9RX, UK.
Campbell S; Create Health, London, EC2V 6ET, UK.
Skates S; Massachusetts General Hospital and Harvard Medical School, Boston, MA, 02115, USA.
McGuire A; London School of Economics, London, WC2A 2AE, UK.
Parmar M; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK.
Jacobs I; Department of Women's Cancer, Institute for Women's Health, University College London, London, WC1E 6AU, UK.; University of New South Wales, Sydney, NSW, 2052, Australia.
Menon U; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials & Methodology, University College London, 90 High Holborn, 2nd Floor, London, WC1V 6LJ, UK. .; Pokaż więcej
Źródło :: Trials [Trials] 2021 Jan 25; Vol. 22 (1), pp. 88. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Early Detection of Cancer/*statistics & numerical data
Mass Screening/*statistics & numerical data
Ovarian Neoplasms/*diagnosis
Registries/*statistics & numerical data
Aged ; Early Detection of Cancer/methods ; Female ; Humans ; Mass Screening/methods ; Middle Aged ; Ovarian Neoplasms/epidemiology ; Sensitivity and Specificity ; United Kingdom/epidemiology
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Epidemiological survey and screening strategy for dengue virus in blood donors from Yunnan Province.
Autorzy :: Li L; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Li Y; Xishuangbanna Blood Center, Xishuangbanna, China.
Lu S; Xishuangbanna Blood Center, Xishuangbanna, China.
Dong J; Xishuangbanna Blood Center, Xishuangbanna, China.
Xu H; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Zhang Q; Xishuangbanna Blood Center, Xishuangbanna, China.
Weng R; Xishuangbanna Blood Center, Xishuangbanna, China.
Yin Y; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
He R; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China.
Fang P; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China.; Anhui Medical University, Hefei, China.
Shi H; Xishuangbanna Blood Center, Xishuangbanna, China.
Yu Y; Xishuangbanna Blood Center, Xishuangbanna, China.
Wu J; Xishuangbanna Blood Center, Xishuangbanna, China. .
Liu Z; Clinical Transfusion Research Center, Institute of Blood Transfusion, Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College, Chengdu, China. .; Key Laboratory of Transfusion Adverse Reactions, CAMS, Chengdu, China. .
Hess JR; Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, Seattle, USA.; Pokaż więcej
Źródło :: BMC infectious diseases [BMC Infect Dis] 2021 Jan 22; Vol. 21 (1), pp. 104. Date of Electronic Publication: 2021 Jan 22.
Typ publikacji :: Journal Article
MeSH Terms :: Blood Donors*
Dengue/*diagnosis
Dengue/*epidemiology
Dengue Virus/*isolation & purification
Mass Screening/*methods
Adult ; Antibodies, Viral/blood ; China/epidemiology ; Dengue/blood ; Dengue Virus/genetics ; Dengue Virus/immunology ; Female ; Humans ; Male ; Mass Screening/statistics & numerical data ; Middle Aged ; Prevalence ; RNA, Viral/genetics ; Viral Nonstructural Proteins/genetics ; Young Adult
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 17 17.

Tytuł :: Controlling COVID-19 Pandemic: A Mass Screening Experience in Saudi Arabia.
Autorzy :: Khan AA; Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.; Global Center for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Alahdal HM; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Alotaibi RM; Faculty of Computing and Information Technology, King Abdulaziz University, Jeddah, Saudi Arabia.
Sonbol HS; Department of Biology, College of Science, Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.
Almaghrabi RH; Department of Pediatrics, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
Alsofayan YM; Global Center for Mass Gatherings Medicine, Ministry of Health, Riyadh, Saudi Arabia.
Althunayyan SM; Department of Accident and Trauma, Prince Sultan Bin Abdulaziz College for Emergency Medical Services, King Saud University, Riyadh, Saudi Arabia.
Alsaif FA; Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Almudarra SS; Field Epidemiology Training Program, Ministry of Health, Riyadh, Saudi Arabia.
Alabdulkareem KI; Al Imam Mohammad Ibn Saud Islamic University, Riyadh, Saudi Arabia.
Assiri AM; Ministry of Health, Riyadh, Saudi Arabia.
Jokhdar HA; Deputyship of Public Health, Ministry of Health, Riyadh, Saudi Arabia.; Pokaż więcej
Źródło :: Frontiers in public health [Front Public Health] 2021 Jan 18; Vol. 8, pp. 606385. Date of Electronic Publication: 2021 Jan 18 (Print Publication: 2020).
Typ publikacji :: Journal Article
MeSH Terms :: Mass Screening*
COVID-19/*epidemiology
Adult ; Cross-Sectional Studies ; Female ; Humans ; Infection Control ; Male ; Middle Aged ; Retrospective Studies ; SARS-CoV-2/isolation & purification ; Saudi Arabia/epidemiology ; Sex Factors
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 18 18.

Tytuł :: Screening inhibitors for blocking UHRF1-methylated DNA interaction with capillary electrophoresis.
Autorzy :: Lou C; State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China; School of physical science and technology, ShanghaiTech University, Haike Road 100, Shanghai, 200120, China; University of Chinese Academy of Sciences.
Ye X; State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China; School of physical science and technology, ShanghaiTech University, Haike Road 100, Shanghai, 200120, China; University of Chinese Academy of Sciences.
Chen G; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201210, China.
Zhu J; Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 26 Qiuyue Road, Shanghai 201210, China.
Kang J; State Key Laboratory of Bioorganic and Natural Products Chemistry, Center for Excellence in Molecular Synthesis, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, 345 Lingling Road, Shanghai 200032, China; School of physical science and technology, ShanghaiTech University, Haike Road 100, Shanghai, 200120, China. Electronic address: .; Pokaż więcej
Źródło :: Journal of chromatography. A [J Chromatogr A] 2021 Jan 11; Vol. 1636, pp. 461790. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :: Journal Article
MeSH Terms :: Drug Screening Assays, Antitumor*
Antineoplastic Agents/*analysis
Antineoplastic Agents/*pharmacology
CCAAT-Enhancer-Binding Proteins/*metabolism
DNA Methylation/*genetics
Electrophoresis, Capillary/*methods
Ubiquitin-Protein Ligases/*metabolism
Animals ; Antineoplastic Agents/chemistry ; DNA Methylation/drug effects ; Flavanones/chemistry ; Flavanones/pharmacology ; Humans ; Kinetics ; Mitoxantrone/chemistry ; Mitoxantrone/pharmacology ; Proanthocyanidins/chemistry ; Proanthocyanidins/pharmacology
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 19 19.

Tytuł :: Consequences of screening in colorectal cancer (COS-CRC): development and dimensionality of a questionnaire.
Autorzy :: Malmqvist J; The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1514, Copenhagen, Denmark. .; Primary Healthcare Research Unit, Region Zealand, Alléen 15, 4180, Soroe, Denmark. .
Siersma V; The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1514, Copenhagen, Denmark.
Bang CW; The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1514, Copenhagen, Denmark.
Brodersen J; The Research Unit for General Practice and Section of General Practice, Department of Public Health, University of Copenhagen, Oester Farimagsgade 5, 1514, Copenhagen, Denmark.; Primary Healthcare Research Unit, Region Zealand, Alléen 15, 4180, Soroe, Denmark.; Pokaż więcej
Źródło :: BMC psychology [BMC Psychol] 2021 Jan 07; Vol. 9 (1), pp. 7. Date of Electronic Publication: 2021 Jan 07.
Typ publikacji :: Journal Article
MeSH Terms :: Early Detection of Cancer*/psychology
Mass Screening*/psychology
Colorectal Neoplasms/*diagnosis
Colorectal Neoplasms/psychology ; Focus Groups ; Humans ; Patient Reported Outcome Measures ; Psychometrics ; Qualitative Research ; Reproducibility of Results ; Surveys and Questionnaires
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 20 20.

Tytuł :: The Rapid Rise in Cutaneous Melanoma Diagnoses.
Autorzy :: Welch HG; From the Center for Surgery and Public Health, Brigham and Women's Hospital, Boston (H.G.W.); the Department of Pathology, Yale University School of Medicine, New Haven, CT (B.L.M.); and the Division of Dermatology, Dell Medical School, University of Texas, Austin (A.S.A.).
Mazer BL; From the Center for Surgery and Public Health, Brigham and Women's Hospital, Boston (H.G.W.); the Department of Pathology, Yale University School of Medicine, New Haven, CT (B.L.M.); and the Division of Dermatology, Dell Medical School, University of Texas, Austin (A.S.A.).
Adamson AS; From the Center for Surgery and Public Health, Brigham and Women's Hospital, Boston (H.G.W.); the Department of Pathology, Yale University School of Medicine, New Haven, CT (B.L.M.); and the Division of Dermatology, Dell Medical School, University of Texas, Austin (A.S.A.).; Pokaż więcej
Źródło :: The New England journal of medicine [N Engl J Med] 2021 Jan 07; Vol. 384 (1), pp. 72-79.
Typ publikacji :: Journal Article
MeSH Terms :: Mass Screening/*standards
Medical Overuse/*trends
Melanoma/*epidemiology
Skin Neoplasms/*epidemiology
Ultraviolet Rays/*adverse effects
Biopsy/trends ; Diagnostic Errors ; Female ; Humans ; Incidence ; Male ; Mass Screening/economics ; Mass Screening/trends ; Melanoma/diagnosis ; Melanoma/mortality ; Melanoma/pathology ; Risk Factors ; Skin Neoplasms/diagnosis ; Skin Neoplasms/mortality ; Skin Neoplasms/pathology ; Sunbathing/trends ; Sunburn/complications ; Sunlight/adverse effects ; United States/epidemiology
: Czasopismo naukowe

Szczegóły

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""screening"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język